Status:
ACTIVE_NOT_RECRUITING
Early Point-of-Service Social and Behavioral Determinants of Health (SBDOH) Screening and Enhanced Navigation on Care Delivery for Patients With Breast Cancer
Lead Sponsor:
Abramson Cancer Center at Penn Medicine
Collaborating Sponsors:
Gilead Sciences
Conditions:
Breast Cancer
Social Determinants of Health (SDOH)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overarching goal of this project is to optimize the collection of social and behavioral determinants of health (SBDOH) for patients with a pathological diagnosis of breast cancer at Penn Medicine....
Detailed Description
The investigators will conduct a patient-level, pragmatic opt-out trial to test implementation of a comprehensive, tech-enabled platform for administration of a validated SBDOH screening tool in contr...
Eligibility Criteria
Inclusion
- Based on available EHR data, patients will be eligible for Activities 1 and 2 if they:
- Are referred to one of the following locations for surgical consult following a new diagnosis of operable (Stage 0-III) breast cancer: the Hospital of the University of Pennsylvania (HUP), Penn Presbyterian Medical Center (PPMC), Pennsylvania Hospital (PAH), and Penn Medicine Radnor
- Are female
- Are 18 years of age or older, and
- Are able to read and speak English or Spanish
- Clinicians and clinical leaders will be eligible for participation in Activity 2 if they:
- Presently work as a clinician or clinical leader in breast surgery or oncology
- Access PennChart as an aspect of their clinical duties
- Are 18 years of age or older
- Are able to read and speak English or Spanish
Exclusion
- Based on available EHR data, patients will be ineligible if they:
- Are listed as not wanting to be contacted or solicited for research;
- Have known metastatic disease at time of enrollment; and/or
- Do not otherwise meet all of the enrollment criteria
- Clinicians and clinical leaders will be ineligible for participation in Activity 2 if they:
- Are not presently engaged in clinical duties or
- Do not otherwise meet all of the enrollment criteria
- This study will not exclude men or nonbinary people who may be diagnosed with breast cancer, but investigators anticipate the sample size for these characteristics will be too small to support meaningful analysis.
Key Trial Info
Start Date :
March 11 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 11 2026
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT06019988
Start Date
March 11 2024
End Date
March 11 2026
Last Update
July 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104